It would be interesting to study this in colorectal cancer but because we could not validate DCR1 methylation as predictive marker for irinotecan treatment response, we feel that functional experimental analyses to dissect the role of DCR1 methylation and its interaction with irinotecan treatment are beyond the scope of the present study. Here, TNFRSF10C is linked to colorectal cancer.